Drug Detail:Havrix pediatric (Hepatitis a pediatric vaccine [ hep-a-tye-tis ])
Drug Class: Viral vaccines
Usual Pediatric Dose for Hepatitis A Prophylaxis
1 year and older: 0.5 mL intramuscularly
- Administer a booster 0.5 mL dose 6 to 18 months after the first dose
Comments:
- Administer in the deltoid region in children 2 years and older.
- Administer in the anterolateral aspect of the thigh in younger children.
Renal Dose Adjustments
Data not available
Liver Dose Adjustments
Data not available
Precautions
CONTRAINDICATIONS:
- Hypersensitivity to any of the ingredients including neomycin
- Hypersensitivity to previous hepatitis A vaccination
Safety and efficacy have not been established in patients younger than 1 year.
To report suspected adverse reactions, contact the Vaccine Adverse Event Reporting System (VAERS) at: https://vaers.hhs.gov
Consult WARNINGS section for additional precautions.
Dialysis
Data not available.
Other Comments
Administration advice:
- For intramuscular use only.
- Do not administer in the gluteal area as a suboptimal response may occur.
- Do not administer intravenously, intradermally, or subcutaneously.
- Primary immunization should be given at least 2 weeks prior to expected exposure to hepatitis A.
Storage requirements:
- Refrigerate; do not freeze
Reconstitution/preparation techniques:
- Shake well before use.